Multidrug resistant acinetobacter baumannii in ventilator associated pneumonia: Prevalence and predictors of mortality Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia Source: Eur Respir J 2009; 34: 1470-1476 Year: 2009
Factors associated with mortality in ventilator associated pneumonia of multidrug resistant acinetobacter baumannii Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Bundles for the prevention of ventilator-associated pneumonia in a Brazilian hospital Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Implications of identifying the pathogen in ventilator-associated pneumonia (VAP) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Ventilator-associated pneumonia (VAP) – Early and late-onset differences Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Microbiological vs non-microbiological confirmed nnventilator ICU-acquired pneumonia Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016
Nursing and healthcare-associated pneumonia requiring hospital admission: Microbiology and clinical outcomes Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia Source: Eur Respir J 2009; 34: 1148-1158 Year: 2009
Carbapenemase producing Klebsiella pneumoniae (KPC+) colonization/infection in a respiratory intensive care unit: Prevalence, length of stay(LOS) and mortality Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Prognostic factors of the patients admitted to intensive care unit with nursing and healthcare-associated pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Health care-associated pneumonia and community-acquired pneumonia: A single-center experience Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
Physical deterioration during hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015
Prevention of nosocomial infections in acute respiratory failure patients Source: Eur Respir J 2003; 22: 72S-76S Year: 2003
Severe community-acquired pneumonia in alcoholic patients hospitalized in intensive care unit Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Can the broad-spectrum antibiotics improve the prognoses of high-risk nursing- and healthcare-associated pneumonia? Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
ICU acquired pneumonia due to pseudomonas aeruginosa with and without multidrug resistance Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia Source: Eur Respir J 2006; 27: 1210-1216 Year: 2006
Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome Source: Eur Respir J 2002; 20: 1483-1489 Year: 2002